查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生物分析測試服務市場報告：2030 年趨勢、預測與競爭分析
市場調查報告書
商品編碼
1416288

生物分析測試服務市場報告：2030 年趨勢、預測與競爭分析

Bioanalytical Testing Services Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

生物分析測試服務的趨勢和預測

預計到 2030 年，全球生物分析測試服務市場將達到約 94 億美元，2024 年至 2030 年的複合年成長率為 15.2%。該市場的主要驅動力是越來越重視開發先進的生物分析技術以加強測試以及外包臨床實驗室服務的成長趨勢。全球生物分析測試服務市場的未來前景廣闊，腫瘤學、感染疾病、傳染病、胃腸病學和心臟病學市場充滿機會。

生物分析測試服務市場洞察

Lucintel 預測，由於慢性病的流行和臨床試驗數量的增加，基於細胞的檢測將在整個預測期內仍然是最大的部分。

由於針對癌症的臨床試驗數量不斷增加，腫瘤學將繼續成為該市場的最大細分市場。

由於專注於開發治療各種疾病的新藥，預計亞太地區將在預測期內實現最高成長。

常問問題

Q1.市場規模為：

A1. 到 2030 年，全球生物分析測試服務市場預計將達到 94 億美元。

Q2.市場成長預測是多少：

A2. 2024年至2030年，全球生物分析測試服務市場預計將以15.2%的複合年成長率成長。

Q3.影響市場成長的主要促進因素是：

A3. 該市場的主要驅動力是越來越重視開發先進的生物分析技術以加強測試以及外包臨床實驗室服務的成長趨勢。

Q4.市場的主要細分市場是：

A4. 生物分析測試服務市場的未來前景廣闊，腫瘤學、神經學、感染疾病、胃腸病學和心臟病學市場充滿機會。

Q5.市場的主要企業是：

A5. 一些主要的生物分析測試服務公司是：

  • Charles River
  • Medpace
  • WuXi AppTec
  • Eurofins Scientific
  • IQVIA
  • SGS SA
  • Laboratory Corporation
  • Intertek
  • Syneos Health
  • ICON

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計，由於慢性病的流行和臨床試驗數量的增加，在整個預測期內基於細胞的檢測仍將是最大的部分。

Q7. 未來五年預計哪些地區的市場成長最大？

A7.由於專注於開發治療各種疾病的新藥，預計亞太地區在預測期內將出現最高成長。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球生物分析測試服務市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球生物分析測試服務市場趨勢（2018-2023）與預測（2024-2030）
  • 按類型分類的全球生物分析測試服務市場
    • 基於細胞的檢測
    • 基於細菌細胞的測定
    • 基於病毒細胞的檢測
    • 病毒測試
    • 體外病毒檢測
    • 體內病毒檢測
    • 物種特異性病毒PCR檢測
    • 方法開發、最佳化和檢驗
    • 其他
  • 全球生物分析測試服務市場（按應用）
    • 瘤
    • 神經病學
    • 感染疾病
    • 消化內科
    • 心臟病
  • 按最終用途分類的全球生物分析測試服務市場
    • 製藥和生物製藥公司
    • 合約開發/製造組織
    • 合約研究組織

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球生物分析測試服務市場（按地區）
  • 北美生物分析測試服務市場
  • 歐洲生物分析測試服務市場
  • 亞太生物分析測試服務市場
  • 其他地區生物分析檢測服務市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按類型分類的全球生物分析測試服務市場成長機會
    • 全球生物分析測試服務市場成長機會（按應用）
    • 全球生物分析測試服務市場成長機會（依最終用途）
    • 按地區分類的全球生物分析測試服務市場成長機會
  • 全球生物分析測試服務市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球生物分析測試服務市場的產能擴張
    • 全球生物分析測試服務市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • Charles River
  • Medpace
  • WuXi AppTec
  • Eurofins Scientific
  • IQVIA
  • SGS SA
  • Laboratory Corporation
  • Intertek
  • Syneos Health
  • ICON
簡介目錄

Bioanalytical Testing Services Trends and Forecast

The future of the global bioanalytical testing services market looks promising with opportunities in the oncology, neurology, infectious diseases, gastroenterology, and cardiology markets. The global bioanalytical testing services market is expected to reach an estimated $9.4 billion by 2030 with a CAGR of 15.2% from 2024 to 2030. The major drivers for this market are increasing emphasis towards the development of advanced bioanalytical technologies for enhanced testing and growing trend of outsourcing laboratory testing services.

A more than 150-page report is developed to help in your business decisions.

Bioanalytical Testing Services by Segment

The study includes a forecast for the global bioanalytical testing services by type, application, end use, and region.

Bioanalytical Testing Services Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Cell-Based Assays
  • Bacterial Cell-Based Assays
  • Viral Cell-Based Assays
  • Virology Testing
  • In Vitro Virology Testing
  • In Vivo Virology Testing
  • Species-Specific Viral PCR Assays
  • Method Development, Optimization, And Validation
  • Others

Bioanalytical Testing Services Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Oncology
  • Neurology
  • Infectious Diseases
  • Gastroenterology
  • Cardiology

Bioanalytical Testing Services Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical And Biopharmaceutical Companies
  • Contract Development And Manufacturing Organizations
  • Contract Research Organizations

Bioanalytical Testing Services Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Bioanalytical Testing Services Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bioanalytical testing services companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bioanalytical testing services companies profiled in this report include-

  • Charles River
  • Medpace
  • WuXi AppTec
  • Eurofins Scientific
  • IQVIA
  • SGS SA
  • Laboratory Corporation
  • Intertek
  • Syneos Health
  • ICON

Bioanalytical Testing Services Market Insights

Lucintel forecasts that cell-based assays will remain the largest segment over the forecast period due to high occurence of chronic diseases and the increasing number of clinical trials.

Within this market, oncology will remain the largest segment due to growing number of clinical trials conducted for cancer.

APAC is expected to witness highest growth over the forecast period due to growing emphasis on developing new drugs for the treatment of various diseases.

Features of the Global Bioanalytical Testing Services Market

Market Size Estimates: Bioanalytical testing services market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bioanalytical testing services market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Bioanalytical testing services market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the bioanalytical testing services market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bioanalytical testing services market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the bioanalytical testing services market size?

Answer: The global bioanalytical testing services market is expected to reach an estimated $9.4 billion by 2030.

Q2. What is the growth forecast for bioanalytical testing services market?

Answer: The global bioanalytical testing services market is expected to grow with a CAGR of 15.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the bioanalytical testing services market?

Answer: The major drivers for this market are increasing emphasis towards the development of advanced bioanalytical technologies for enhanced testing and growing trend of outsourcing laboratory testing services.

Q4. What are the major segments for bioanalytical testing services market?

Answer: The future of the bioanalytical testing services market looks promising with opportunities in the oncology, neurology, infectious diseases, gastroenterology, and cardiology markets.

Q5. Who are the key bioanalytical testing services market companies?

Answer: Some of the key bioanalytical testing services companies are as follows:

  • Charles River
  • Medpace
  • WuXi AppTec
  • Eurofins Scientific
  • IQVIA
  • SGS SA
  • Laboratory Corporation
  • Intertek
  • Syneos Health
  • ICON

Q6. Which bioanalytical testing services market segment will be the largest in future?

Answer: Lucintel forecasts that cell-based assays will remain the largest segment over the forecast period due to high occurence of chronic diseases and the increasing number of clinical trials.

Q7. In bioanalytical testing services market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growing emphasis on developing new drugs for the treatment of various diseases.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the bioanalytical testing services market by type (cell-based assays, bacterial cell-based assays, viral cell-based assays, virology testing, in vitro virology testing, in vivo virology testing, species-specific viral PCR assays, method development, optimization, and validation, and others), application (oncology, neurology, infectious diseases, gastroenterology, and cardiology), end use (pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations, and contract research organizations), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bioanalytical Testing Services Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Bioanalytical Testing Services Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Bioanalytical Testing Services Market by Type
    • 3.3.1: Cell-Based Assays
    • 3.3.2: Bacterial Cell-Based Assays
    • 3.3.3: Viral Cell-Based Assays
    • 3.3.4: Virology Testing
    • 3.3.5: In Vitro Virology Testing
    • 3.3.6: In Vivo Virology Testing
    • 3.3.7: Species-Specific Viral PCR Assays
    • 3.3.8: Method Development, Optimization, and Validation
    • 3.3.9: Others
  • 3.4: Global Bioanalytical Testing Services Market by Application
    • 3.4.1: Oncology
    • 3.4.2: Neurology
    • 3.4.3: Infectious Diseases
    • 3.4.4: Gastroenterology
    • 3.4.5: Cardiology
  • 3.5: Global Bioanalytical Testing Services Market by End Use
    • 3.5.1: Pharmaceutical and Biopharmaceutical Companies
    • 3.5.2: Contract Development and Manufacturing Organizations
    • 3.5.3: Contract Research Organizations

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Bioanalytical Testing Services Market by Region
  • 4.2: North American Bioanalytical Testing Services Market
    • 4.2.1: North American Bioanalytical Testing Services Market by Application: Oncology, Neurology, Infectious Diseases, Gastroenterology, and Cardiology
    • 4.2.2: North American Bioanalytical Testing Services Market by End Use: Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations, and Contract Research Organizations
  • 4.3: European Bioanalytical Testing Services Market
    • 4.3.1: European Bioanalytical Testing Services Market by Application: Oncology, Neurology, Infectious Diseases, Gastroenterology, and Cardiology
    • 4.3.2: European Bioanalytical Testing Services Market by End Use: Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations, and Contract Research Organizations
  • 4.4: APAC Bioanalytical Testing Services Market
    • 4.4.1: APAC Bioanalytical Testing Services Market by Application: Oncology, Neurology, Infectious Diseases, Gastroenterology, and Cardiology
    • 4.4.2: APAC Bioanalytical Testing Services Market by End Use: Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations, and Contract Research Organizations
  • 4.5: ROW Bioanalytical Testing Services Market
    • 4.5.1: ROW Bioanalytical Testing Services Market by Application: Oncology, Neurology, Infectious Diseases, Gastroenterology, and Cardiology
    • 4.5.2: ROW Bioanalytical Testing Services Market by End Use: Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations, and Contract Research Organizations

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Bioanalytical Testing Services Market by Type
    • 6.1.2: Growth Opportunities for the Global Bioanalytical Testing Services Market by Application
    • 6.1.3: Growth Opportunities for the Global Bioanalytical Testing Services Market by End Use
    • 6.1.4: Growth Opportunities for the Global Bioanalytical Testing Services Market by Region
  • 6.2: Emerging Trends in the Global Bioanalytical Testing Services Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Bioanalytical Testing Services Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bioanalytical Testing Services Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Charles River
  • 7.2: Medpace
  • 7.3: WuXi AppTec
  • 7.4: Eurofins Scientific
  • 7.5: IQVIA
  • 7.6: SGS SA
  • 7.7: Laboratory Corporation
  • 7.8: Intertek
  • 7.9: Syneos Health
  • 7.10: ICON